$1.59 Billion is the total value of ARMISTICE CAPITAL, LLC's 61 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CERC | Buy | CERECOR INC | $100,255,000 | -6.2% | 18,429,285 | +0.7% | 6.32% | +8.0% |
| ENR | Buy | ENERGIZER HLDGS INC NEW | $52,087,000 | -10.5% | 1,348,000 | +4.0% | 3.28% | +3.0% |
| DFRG | Buy | DEL FRISCOS RESTAURANT GROUP | $48,755,000 | +35.8% | 6,125,000 | +9.4% | 3.07% | +56.4% |
| VNDA | New | VANDA PHARMACEUTICALS INC | $44,496,000 | – | 3,158,000 | +100.0% | 2.80% | – |
| HAIN | Buy | HAIN CELESTIAL GROUP INCcall | $43,800,000 | +18.4% | 2,000,000 | +25.0% | 2.76% | +36.3% |
| EPC | Buy | EDGEWELL PERS CARE CO | $41,503,000 | -2.7% | 1,540,000 | +58.4% | 2.62% | +12.1% |
| REGN | New | REGENERON PHARMACEUTICALS | $38,812,000 | – | 124,000 | +100.0% | 2.45% | – |
| BURL | Buy | BURLINGTON STORES INC | $38,114,000 | +21.6% | 224,000 | +12.0% | 2.40% | +40.1% |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $37,962,000 | -11.1% | 3,800,000 | +14.6% | 2.39% | +2.4% |
| WBT | Buy | WELBILT INC | $36,606,000 | +11.7% | 2,192,000 | +9.6% | 2.31% | +28.7% |
| LOW | New | LOWES COS INC | $34,612,000 | – | 343,000 | +100.0% | 2.18% | – |
| MNKKQ | New | MALLINCKRODT PUB LTD COcall | $33,048,000 | – | 3,600,000 | +100.0% | 2.08% | – |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $32,946,000 | – | 2,215,600 | +100.0% | 2.08% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $32,064,000 | -9.8% | 380,000 | +2.2% | 2.02% | +3.9% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $26,980,000 | +21.5% | 2,000,000 | +77.3% | 1.70% | +39.9% |
| RH | New | RH | $25,894,000 | – | 224,000 | +100.0% | 1.63% | – |
| SJM | Buy | SMUCKER J M CO | $25,803,000 | +121.5% | 224,000 | +124.0% | 1.63% | +155.0% |
| FIVE | Buy | FIVE BELOW INC | $25,564,000 | +185.8% | 213,000 | +195.8% | 1.61% | +229.0% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $25,291,000 | – | 324,000 | +100.0% | 1.59% | – |
| DBX | Buy | DROPBOX INCcl a | $23,798,000 | +336.7% | 950,000 | +280.0% | 1.50% | +403.4% |
| DPLO | Buy | DIPLOMAT PHARMACY INC | $19,488,000 | +11.8% | 3,200,000 | +6.7% | 1.23% | +28.8% |
| INCY | New | INCYTE CORP | $19,371,000 | – | 228,000 | +100.0% | 1.22% | – |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $19,200,000 | +147.7% | 5,000,000 | +228.9% | 1.21% | +185.4% |
| PLNT | New | PLANET FITNESS INCcl a | $19,124,000 | – | 264,000 | +100.0% | 1.21% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $12,720,000 | +18.9% | 100,000 | +47.1% | 0.80% | +36.9% |
| QSR | New | RESTAURANT BRANDS INTL INC | $12,726,000 | – | 183,000 | +100.0% | 0.80% | – |
| CLLS | Buy | CELLECTIS S Asponsored ads | $12,480,000 | -6.5% | 800,000 | +9.9% | 0.79% | +7.7% |
| JACK | Buy | JACK IN THE BOX INC | $12,209,000 | +25.5% | 150,000 | +25.0% | 0.77% | +44.7% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $9,887,000 | -13.2% | 2,478,000 | +16.7% | 0.62% | 0.0% |
| LULU | New | LULULEMON ATHLETICA INC | $9,731,000 | – | 54,000 | +100.0% | 0.61% | – |
| KMX | New | CARMAX INC | $9,551,000 | – | 110,000 | +100.0% | 0.60% | – |
| GOOS | New | CANADA GOOSE HOLDINGS INC | $8,443,000 | – | 218,000 | +100.0% | 0.53% | – |
| SKX | New | SKECHERS U S A INCcl a | $7,935,000 | – | 252,000 | +100.0% | 0.50% | – |
| SPOT | Buy | SPOTIFY TECHNOLOGY S A | $7,019,000 | +26.4% | 48,000 | +20.0% | 0.44% | +45.7% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $7,006,000 | – | 160,000 | +100.0% | 0.44% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $6,962,000 | – | 68,000 | +100.0% | 0.44% | – |
| FL | New | FOOT LOCKER INC | $6,288,000 | – | 150,000 | +100.0% | 0.40% | – |
| TPR | New | TAPESTRY INC | $3,173,000 | – | 100,000 | +100.0% | 0.20% | – |
| VLRXQ | New | VALERITAS HLDGS INC | $2,777,000 | – | 1,060,000 | +100.0% | 0.18% | – |
| ZFGN | Buy | ZAFGEN INC | $2,592,000 | -55.1% | 2,178,000 | +3.3% | 0.16% | -48.4% |
| BIG | New | BIG LOTS INC | $2,146,000 | – | 75,000 | +100.0% | 0.14% | – |
| PLAY | New | DAVE & BUSTERS ENTMT INC | $2,024,000 | – | 50,000 | +100.0% | 0.13% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.